Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial

Samuel A. Wells, Bruce G. Robinson, Robert F. Gagel et al. · Journal of Clinical Oncology · 2011 · 1.5K citations · Full text

Cabozantinib in Progressive Medullary Thyroid Cancer

Rossella Elisei, Martin Schlumberger, Stefan Müller et al. · Journal of Clinical Oncology · 2013 · 1.2K citations · Full text

Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma

Cristina E. Tognon, Stevan R. Knezevich, David G. Huntsman et al. · Cancer Cell · 2002 · 894 citations · Full text

Radiation Oncology, Primary Event, Etv6-ntrk3 Gene Fusion +8

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

Doron Lipson, Marzia Capelletti, Roman Yelensky et al. · Nature Medicine · 2012 · 860 citations · Full text

Tumor Biology, Radiation Oncology, Lung Cancer Biopsies +13